Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heidi T May

Showing results (81-90 of 153) with videos related to

Pageof 16
Sort By:
Journal of Cardiovascular Electrophysiology|January 14, 2023
Increasing time between first diagnosis of atrial fibrillation and catheter ablation adversely affects long-term outcomes in patients with and without structural heart diseaseAndrew J Sessions, Heidi T May, Brian G Crandall, et al.
Cardiology|August 31, 2006
Homocysteine levels are associated with increased risk of congestive heart failure in patients with and without coronary artery diseaseHeidi T May, Rami Alharethi, Jeffrey L Anderson, et al.
Circulation|September 14, 2007
Surgical revascularization is associated with improved long-term outcomes compared with percutaneous stenting in most subgroups of patients with multivessel coronary artery disease: results from the Intermountain Heart RegistryTami L Bair, Joseph B Muhlestein, Heidi T May, et al.
JACC. Advances|June 28, 2024
Impact of Active vs Passive Statin Selection for Primary Prevention: The CorCal Vanguard TrialJeffrey L Anderson, Kirk U Knowlton, Heidi T May, et al.
Journal of the American College of Cardiology|July 18, 2006
The reduction of inflammatory biomarkers by statin, fibrate, and combination therapy among diabetic patients with mixed dyslipidemia: the DIACOR (Diabetes and Combined Lipid Therapy Regimen) studyJoseph B Muhlestein, Heidi T May, Jonathan R Jensen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 9, 2018
Practical laboratory-based clinical decision tools and associations with short-term bleeding and mortality outcomesKevin G Graves, Joseph B Muhlestein, Donald L Lappé, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 15, 2011
Efficacy and safety of ventricular tachycardia ablation with mechanical circulatory support compared with substrate-based ablation techniquesT Jared Bunch, Andy Darby, Heidi T May, et al.
Journal of Cardiovascular Electrophysiology|August 29, 2017
Long-term aspirin does not lower risk of stroke and increases bleeding risk in low-risk atrial fibrillation ablation patientsVictoria Jacobs, Heidi T May, Tami L Bair, et al.
The American Journal of Cardiology|August 23, 2006
Relation of serum total cholesterol, C-reactive protein levels, and statin therapy to survival in heart failureHeidi T May, Joseph B Muhlestein, John F Carlquist, et al.
Journal of Cardiovascular Electrophysiology|December 24, 2014
Five-year outcomes of catheter ablation in patients with atrial fibrillation and left ventricular systolic dysfunctionT Jared Bunch, Heidi T May, Tami L Bair, et al.
Pageof 16

Showing results (81-90 of 153) with videos related to

Sort By:
Pageof 16
Journal of Cardiovascular Electrophysiology|January 14, 2023
Increasing time between first diagnosis of atrial fibrillation and catheter ablation adversely affects long-term outcomes in patients with and without structural heart diseaseAndrew J Sessions, Heidi T May, Brian G Crandall, et al.
Cardiology|August 31, 2006
Homocysteine levels are associated with increased risk of congestive heart failure in patients with and without coronary artery diseaseHeidi T May, Rami Alharethi, Jeffrey L Anderson, et al.
Circulation|September 14, 2007
Surgical revascularization is associated with improved long-term outcomes compared with percutaneous stenting in most subgroups of patients with multivessel coronary artery disease: results from the Intermountain Heart RegistryTami L Bair, Joseph B Muhlestein, Heidi T May, et al.
JACC. Advances|June 28, 2024
Impact of Active vs Passive Statin Selection for Primary Prevention: The CorCal Vanguard TrialJeffrey L Anderson, Kirk U Knowlton, Heidi T May, et al.
Journal of the American College of Cardiology|July 18, 2006
The reduction of inflammatory biomarkers by statin, fibrate, and combination therapy among diabetic patients with mixed dyslipidemia: the DIACOR (Diabetes and Combined Lipid Therapy Regimen) studyJoseph B Muhlestein, Heidi T May, Jonathan R Jensen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 9, 2018
Practical laboratory-based clinical decision tools and associations with short-term bleeding and mortality outcomesKevin G Graves, Joseph B Muhlestein, Donald L Lappé, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 15, 2011
Efficacy and safety of ventricular tachycardia ablation with mechanical circulatory support compared with substrate-based ablation techniquesT Jared Bunch, Andy Darby, Heidi T May, et al.
Journal of Cardiovascular Electrophysiology|August 29, 2017
Long-term aspirin does not lower risk of stroke and increases bleeding risk in low-risk atrial fibrillation ablation patientsVictoria Jacobs, Heidi T May, Tami L Bair, et al.
The American Journal of Cardiology|August 23, 2006
Relation of serum total cholesterol, C-reactive protein levels, and statin therapy to survival in heart failureHeidi T May, Joseph B Muhlestein, John F Carlquist, et al.
Journal of Cardiovascular Electrophysiology|December 24, 2014
Five-year outcomes of catheter ablation in patients with atrial fibrillation and left ventricular systolic dysfunctionT Jared Bunch, Heidi T May, Tami L Bair, et al.
Pageof 16